Pharmaceutical Affairs Act Article 48-18

If any of the following matters occur to the applicant for a generic drug license subject to the marketing exclusivity period, the central competent health authority may issue generic drug licenses to other applicants without being restricted by Paragraph 1 of Article 48-16:1. Failure to collect the drug license within the period prescribed by the central competent health authority.2. Failure to abide by Paragraph 1 of Article 48-17.3. All the patents declared under Subparagraph 4 of Article 48-9 have been extinguished.